Study Design & Methodology Flashcards
7 cards from real CPI practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Study Design & Methodology flashcards as text
Which of the following is an example of an adaptive trial design?
Answer: Pre-specified sample size reestimation at interim
Adaptive designs allow pre-specified modifications (such as sample size reestimation) based on interim data while maintaining trial integrity.
In a crossover trial, the 'washout period' serves to:
Answer: Eliminate carryover effects from prior treatment
The washout period allows prior treatment effects to dissipate before participants receive the next treatment, preventing carryover bias.
A researcher compares outcomes between patients who chose drug A versus drug B without randomization. The main methodological threat is:
Answer: Confounding by indication
Confounding by indication occurs when the reason for choosing a treatment (indication) is also related to the outcome, distorting effect estimates.
The CONSORT statement was developed primarily to improve reporting of:
Answer: Randomized controlled trials
CONSORT (Consolidated Standards of Reporting Trials) provides a checklist and flow diagram to improve transparency in RCT reporting.
Which bias can occur when study participants who drop out differ systematically from those who complete the study?
Answer: Attrition bias
Attrition bias (loss-to-follow-up bias) occurs when dropouts differ from completers in ways that affect the outcome, distorting results.
A Phase I clinical trial primarily aims to:
Answer: Determine maximum tolerated dose and safety profile
Phase I trials focus on safety, pharmacokinetics, and determining the maximum tolerated dose, typically in a small number of participants.
Which of the following best describes a 'pragmatic' clinical trial?
Answer: Real-world conditions testing whether a treatment works in practice
Pragmatic trials test interventions under real-world clinical conditions with broad eligibility to assess effectiveness in routine practice.